Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine effects during propofol-sufentanil versus propofol-remifentanil anesthesia in off-pump CABG
NL-OMON38529Active, not recruiting
- Sponsor
- Anesthesiologie - Onderzoeksbureau (UMCG)
- Start
- Jun 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of atropine, propofol, sufentanil and remifentanil in coronary arteriosclerosis (2 arms), sponsored by Anesthesiologie - Onderzoeksbureau (UMCG). Primary endpoint: Change in cardiac output. Started Jun 2013; status: active, not recruiting.
02
Drugs
atropinepropofolsufentanilremifentanil
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on NL-OMON38529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38529.